Private Advisor Group’s Medicus Pharma Warrant MDCXW Stock Holding History

Private Advisor Group’s Portfolio MDCXW Stock Details MDCXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.4K	Hold	49,000	–	–	﹤0.01%	2609
2025 Q4	$39.2K	Buy	49,000 +5,000	+11%	+$4.67K	﹤0.01%	2534
2025 Q3	$31.7K	Buy	44,000 +5,000	+13%	+$4.31K	﹤0.01%	2478
2025 Q2	$34.5K	Buy	39,000 +24,000	+160%	+$25.5K	﹤0.01%	2371
2025 Q1	$10.5K	Buy	+15,000	New	+$15.6K	﹤0.01%	2285

Other funds holding MDCXW

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

CCM

Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Private Advisor Group's MDCXW Position: Q1 2026 in Review

Private Advisor Group held its Medicus Pharma Warrant (MDCXW) position steady in Q1 2026 at 49,000 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2609.

Private Advisor Group first reported a position in MDCXW in Q1 2025 and has held it in 5 quarters since. The position peaked at $39.2K in Q4 2025. 6 funds tracked by Wall St. Rank hold MDCXW as of Q1 2026.

Private Advisor Group held 49,000 shares of Medicus Pharma Warrant worth $27.4K as of Q1 2026.
Private Advisor Group left its Medicus Pharma Warrant share count unchanged in Q1 2026.
Medicus Pharma Warrant made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2609 holding.
Private Advisor Group first reported a position in Medicus Pharma Warrant in Q1 2025 and has held it in 5 quarters since.
Private Advisor Group's Medicus Pharma Warrant position peaked at $39.2K in Q4 2025.
6 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.